Header Logo

Connection

DAVID ALLISON to Weight Loss

Back to Details
This is a "connection" page, showing publications DAVID ALLISON has written about Weight Loss.
DAVID ALLISON
Connection Strength
6.857
Weight Loss
  1. Measurement rigor is not a substitute for design rigor in causal inference: increased physical activity does cause (modest) weight loss. Int J Obes (Lond). 2023 01; 47(1):3-4.
    View in: PubMed
    Score: 0.617
  2. Change in study randomization allocation needs to be included in statistical analysis: comment on 'Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study'. Breast Cancer Res Treat. 2019 05; 175(1):263-264.
    View in: PubMed
    Score: 0.474
  3. Weight Cycling Increases Longevity Compared with Sustained Obesity in Mice. Obesity (Silver Spring). 2018 11; 26(11):1733-1739.
    View in: PubMed
    Score: 0.466
  4. Weighing the Evidence of Common Beliefs in Obesity Research. Crit Rev Food Sci Nutr. 2015; 55(14):2014-53.
    View in: PubMed
    Score: 0.357
  5. Randomized controlled trial examining expectancy effects on the accuracy of weight measurement. Clin Obes. 2015 Feb; 5(1):38-41.
    View in: PubMed
    Score: 0.356
  6. Energy intake and weight loss. JAMA. 2014 Dec 24-31; 312(24):2687-8.
    View in: PubMed
    Score: 0.355
  7. Predicting adult weight change in the real world: a systematic review and meta-analysis accounting for compensatory changes in energy intake or expenditure. Int J Obes (Lond). 2015 Aug; 39(8):1181-7.
    View in: PubMed
    Score: 0.352
  8. Association of run-in periods with weight loss in obesity randomized controlled trials. Obes Rev. 2014 Jan; 15(1):68-73.
    View in: PubMed
    Score: 0.327
  9. Randomized controlled trial of the Medifast 5 & 1 Plan for weight loss. Int J Obes (Lond). 2013 Dec; 37(12):1571-8.
    View in: PubMed
    Score: 0.317
  10. Myths, presumptions, and facts about obesity. N Engl J Med. 2013 Jan 31; 368(5):446-54.
    View in: PubMed
    Score: 0.313
  11. No compelling evidence that sibutramine prolongs life in rodents despite providing a dose-dependent reduction in body weight. Int J Obes (Lond). 2011 May; 35(5):652-7.
    View in: PubMed
    Score: 0.268
  12. Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods. PLoS One. 2009 Aug 13; 4(8):e6624.
    View in: PubMed
    Score: 0.246
  13. Industry funding and the reporting quality of large long-term weight loss trials. Int J Obes (Lond). 2008 Oct; 32(10):1531-6.
    View in: PubMed
    Score: 0.230
  14. The potential role of soyfoods in weight and adiposity reduction: an evidence-based review. Obes Rev. 2008 May; 9(3):219-35.
    View in: PubMed
    Score: 0.225
  15. The effects of intentional weight loss as a latent variable problem. Stat Med. 2005 Mar 30; 24(6):941-54.
    View in: PubMed
    Score: 0.181
  16. Impact of sustained calorie restriction and weight cycling on body composition in high-fat diet-fed male and female C57BL/6J mice. Obesity (Silver Spring). 2024 May; 32(5):959-968.
    View in: PubMed
    Score: 0.170
  17. A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial. Eur J Clin Nutr. 2003 Apr; 57(4):514-22.
    View in: PubMed
    Score: 0.158
  18. Weight loss causes increased mortality: cons. Obes Rev. 2003 Feb; 4(1):9-16.
    View in: PubMed
    Score: 0.156
  19. Randomized trial of a novel lifestyle intervention compared with the Diabetes Prevention Program for weight loss in adult dependents of military service members. Am J Clin Nutr. 2021 10 04; 114(4):1546-1559.
    View in: PubMed
    Score: 0.143
  20. Neglecting regression to the mean continues to lead to unwarranted conclusions: Letter regarding "The magnitude of weight loss induced by metformin is independently associated with BMI at baseline in newly diagnosed type 2 diabetes: Post-hoc analysis from data of a phase IV open-labeled trial". Adv Clin Exp Med. 2019 Nov; 28(11):1569-1570.
    View in: PubMed
    Score: 0.125
  21. Rigorous control conditions diminish treatment effects in weight loss-randomized controlled trials. Int J Obes (Lond). 2016 06; 40(6):895-8.
    View in: PubMed
    Score: 0.094
  22. Increased fruit and vegetable intake has no discernible effect on weight loss: a systematic review and meta-analysis. Am J Clin Nutr. 2014 Aug; 100(2):567-76.
    View in: PubMed
    Score: 0.086
  23. The effectiveness of breakfast recommendations on weight loss: a randomized controlled trial. Am J Clin Nutr. 2014 Aug; 100(2):507-13.
    View in: PubMed
    Score: 0.086
  24. Empirical evidence does not support an association between less ambitious pre-treatment goals and better treatment outcomes: a meta-analysis. Obes Rev. 2013 Jul; 14(7):532-40.
    View in: PubMed
    Score: 0.079
  25. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012 Feb; 95(2):297-308.
    View in: PubMed
    Score: 0.072
  26. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012 Feb; 20(2):330-42.
    View in: PubMed
    Score: 0.072
  27. Meta-analysis of studies of a specific delivery mode for a modified-carbohydrate diet. J Hum Nutr Diet. 2011 Dec; 24(6):525-35.
    View in: PubMed
    Score: 0.071
  28. Sample size in obesity trials: patient perspective versus current practice. Med Decis Making. 2010 Jan-Feb; 30(1):68-75.
    View in: PubMed
    Score: 0.061
  29. Effects of a reimbursement incentive on enrollment in a weight control program. Obesity (Silver Spring). 2007 Nov; 15(11):2733-8.
    View in: PubMed
    Score: 0.054
  30. Obesity: person and population. Obesity (Silver Spring). 2006 Jul; 14 Suppl 4:156S-159S.
    View in: PubMed
    Score: 0.049
  31. Dietary supplements in weight reduction. J Am Diet Assoc. 2005 May; 105(5 Suppl 1):S80-6.
    View in: PubMed
    Score: 0.046
  32. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. Int J Obes Relat Metab Disord. 2004 Nov; 28(11):1411-9.
    View in: PubMed
    Score: 0.044
  33. Effects of outcome-driven insurance reimbursement on short-term weight control. Int J Obes Relat Metab Disord. 2003 Nov; 27(11):1423-9.
    View in: PubMed
    Score: 0.041
  34. Treatment and prevention of obesity: what works, what doesn't work, and what might work. Lipids. 2003 Feb; 38(2):147-55.
    View in: PubMed
    Score: 0.039
  35. Randomized controlled trial of a novel lifestyle intervention used with or without meal replacements in work sites. Obesity (Silver Spring). 2023 02; 31(2):374-389.
    View in: PubMed
    Score: 0.039
  36. Sexual dimorphism in the energy content of weight change. Int J Obes Relat Metab Disord. 2002 Oct; 26(10):1339-48.
    View in: PubMed
    Score: 0.038
  37. Novel mathematical models for investigating topics in obesity. Adv Nutr. 2014 Sep; 5(5):561-2.
    View in: PubMed
    Score: 0.022
  38. Reduced risk of liver-function-test abnormalities and new gallstone formation with weight loss on 3350-kJ (800-kcal) formula diets. Am J Clin Nutr. 1994 Aug; 60(2):249-54.
    View in: PubMed
    Score: 0.022
  39. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA. 1998 Nov 11; 280(18):1596-600.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.